share_log

Lyra Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Steven A. Cohen(5.8%),Point72 Asset Management, L.P.(5.7%), etc.

Lyra Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Steven A. Cohen(5.8%),Point72 Asset Management, L.P.(5.7%)等

美股SEC公告 ·  02/15 06:41
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息